Use and outcomes of epoetin alfa and darbepoetin alfa for anemic cancer patients in outpatient community practice settings.

被引：1
|
作者：
Fahrbach, KR
Frame, D
Sercus, B
Schenkel, B
机构：
[1] Metaworks Inc, Res & Stat, Medford, MA USA
[2] Johnson & Johnson Pharmaceut Serv LLC, Hlth Econ & Pricing, Raritan, NJ USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.5588.5588
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5588
引用
收藏
页码：485B / 486B
页数：2
相关论文
共 50 条
  • [41] Comparison of epoetin alfa and darbepoetin alfa doses routinely used in clinical practice in Department of Defense beneficiaries
    Cota, J. M.
    Bretzke, D. R.
    Allerman, A. A.
    Meade, D. J.
    Trice, S.
    VALUE IN HEALTH, 2007, 10 (03) : A154 - A154
  • [42] Darbepoetin alfa - A review of its use in patients with cancer
    Jung, LL
    Schwartz, RN
    CANCER PRACTICE, 2002, 10 (06) : 327 - 330
  • [43] Fluctuations in haemoglobin levels in haemodialysis patients receiving intravenous epoetin alfa or intravenous darbepoetin alfa
    Walker, Rowan
    Pussell, Bruce A.
    NEPHROLOGY, 2007, 12 (05) : 448 - 451
  • [44] Pharmacokinetics and pharmacodynamics of darbepoetin alfa and epoetin in patients undergoing dialysis
    Allon, M
    Kleininan, K
    Walczyk, M
    Kaupke, C
    Messer-Mann, L
    Olson, K
    Heatherington, AC
    Maroni, BJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (05) : 546 - 555
  • [45] Fluctuations in haemoglobin levels in haemodialysis patients receiving intravenous epoetin alfa or intravenous darbepoetin alfa
    Walker, Rowan
    Pussell, Bruce
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 348 - 348
  • [46] A systematic review and economic evaluation of epoetin alfa, epoetin beta and darbepoetin alfa in anaemia associated with cancer, especially that attributable to cancer treatment
    Wilson, J.
    Yao, G. L.
    Raftery, J.
    Bohlius, J.
    Brunskill, S.
    Sandercock, J.
    Bayliss, S.
    Moss, P.
    Stanworth, S.
    Hyde, C.
    HEALTH TECHNOLOGY ASSESSMENT, 2007, 11 (13) : 1 - +
  • [47] OBSERVATIONAL STUDY OF ANEMIC PATIENTS WITH PRE-DIALYSIS CHRONIC KIDNEY DISEASE (CKD) CONVERTING FROM DARBEPOETIN ALFA (DARB) TO EPOETIN ALFA (EPO)
    Lunde, Martin
    Jackson, James
    Lunacsek, Orsolya
    Bailey, Robert A.
    Senbetta, Mekre
    McKenzie, R. Scott
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A60 - A60
  • [48] CONVERSION FACTOR OF EPOETIN-ALFA/DARBEPOETIN-ALFA ADMINISTRED INTRAVENOUSLY IN HEMODIALYSIS STABLE PATIENTS
    Icardi, Andrea
    Sacco, Paolo
    Salvatore, Francesca
    Romano, Umberto
    NEPHROLOGY, 2005, 10 : A319 - A319
  • [49] Post discharge Epoetin Alfa dose requirements for dialysis patients converted to Darbepoetin Alfa during hospitalization
    Sarac, E
    Chikyarappa, A
    Sabol, B
    Dass, B
    Gemmel, D
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (04) : A46 - A46
  • [50] Dose conversion from epoetin alfa to darbepoetin alfa for patients with chronic kidney disease receiving hemodialysis
    Barnett, AI
    Crémieux, PY
    PHARMACOTHERAPY, 2003, 23 (05): : 690 - 693
12345